Pathophysiology of Asthma-Chronic Obstructive Pulmonary Disease Overlap.


Journal

Immunology and allergy clinics of North America
ISSN: 1557-8607
Titre abrégé: Immunol Allergy Clin North Am
Pays: United States
ID NLM: 8805635

Informations de publication

Date de publication:
08 2022
Historique:
entrez: 14 8 2022
pubmed: 15 8 2022
medline: 17 8 2022
Statut: ppublish

Résumé

Asthma-chronic obstructive pulmonary disease (COPD) overlap (ACO) is a condition in which a person has clinical and biological features of both asthma and COPD. The pathophysiology behind the development of ACO is complex, with various inflammatory cells, cytokines, environmental factors, and architectural changes within the airways, all affecting a patient's clinical manifestation. A better understanding of the pathophysiologic mechanisms resulting in the development of ACO will help us to better identify potential drug targets and improve symptom burden and overall quality of life for patients living with ACO.

Identifiants

pubmed: 35965042
pii: S0889-8561(22)00030-3
doi: 10.1016/j.iac.2022.04.008
pmc: PMC10355375
mid: NIHMS1910482
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

521-532

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL125734
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL007085
Pays : United States

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Disclosure Dr F. Holguin is a member of the ASPEN trial adjudication committee, INSMED.

Références

J Allergy Clin Immunol. 2014 Jan;133(1):207-16.e1-11
pubmed: 24176116
N Engl J Med. 2007 Oct 11;357(15):1487-95
pubmed: 17928596
Am J Respir Crit Care Med. 2003 Jan 1;167(1):24-31
pubmed: 12406856
N Engl J Med. 2010 Sep 23;363(13):1211-1221
pubmed: 20860503
Immunol Allergy Clin North Am. 2021 Nov;41(4):599-611
pubmed: 34602231
Eur Respir J. 2004 Jun;23(6):932-46
pubmed: 15219010
Immunol Allergy Clin North Am. 2020 Nov;40(4):565-573
pubmed: 33012320
J Immunol. 2008 Aug 15;181(4):2790-8
pubmed: 18684970
Mol Aspects Med. 2022 Jun;85:101021
pubmed: 34521557
Respir Res. 2019 Oct 23;20(1):229
pubmed: 31647021
Chest. 2006 Mar;129(3):661-8
pubmed: 16537865
Chest. 2013 Feb 1;143(2):494-501
pubmed: 23381314
Annu Rev Pathol. 2015;10:511-45
pubmed: 25423350
JAMA. 2019 Aug 13;322(6):546-556
pubmed: 31408135
Chest. 2013 Jul;144(1):266-273
pubmed: 23880677
J Pediatr (Rio J). 2022 Mar-Apr;98 Suppl 1:S86-S95
pubmed: 34922896
N Engl J Med. 2010 Dec 2;363(23):2233-47
pubmed: 21121836
Clin Sci (Lond). 2017 Jul 1;131(13):1541-1558
pubmed: 28659395
Pharmacol Ther. 2017 Jan;169:104-112
pubmed: 27365223
Nat Rev Immunol. 2013 Jan;13(1):9-22
pubmed: 23154224
Am J Respir Crit Care Med. 2009 Dec 15;180(12):1170-8
pubmed: 19797761
Nat Genet. 2018 Jan;50(1):42-53
pubmed: 29273806
Am Rev Respir Dis. 1993 Feb;147(2):301-6
pubmed: 8430952
J Clin Invest. 2018 Mar 1;128(3):997-1009
pubmed: 29400693
N Engl J Med. 2004 Jun 24;350(26):2645-53
pubmed: 15215480
J Allergy Clin Immunol. 2005 Sep;116(3):544-9
pubmed: 16159622
Am J Respir Cell Mol Biol. 2011 Oct;45(4):753-60
pubmed: 21317378
Lancet Respir Med. 2013 Jul;1(5):386-94
pubmed: 24429203
Respir Med. 2013 Jul;107(7):959-66
pubmed: 23639272
Am J Respir Crit Care Med. 1999 Aug;160(2):711-7
pubmed: 10430750
Clin Exp Allergy. 2008 Jun;38(6):872-97
pubmed: 18498538
J Clin Invest. 2008 Nov;118(11):3546-56
pubmed: 18982161
J Allergy Clin Immunol. 2018 Jun;141(6):2027-2036.e12
pubmed: 29709671
Environ Sci Pollut Res Int. 2020 Jul;27(20):24815-24830
pubmed: 32363462
Am J Respir Crit Care Med. 2003 May 15;167(10):1360-8
pubmed: 12531777
Ann Allergy Asthma Immunol. 2017 Mar;118(3):241-245
pubmed: 28284529
Am J Respir Crit Care Med. 1998 Oct;158(4):1277-85
pubmed: 9769292
Clin Exp Allergy. 2004 Aug;34(8):1156-67
pubmed: 15298554
Am J Respir Crit Care Med. 1997 Mar;155(3):852-7
pubmed: 9117016
Nat Rev Immunol. 2015 Jan;15(1):57-65
pubmed: 25534623
Nat Commun. 2020 Oct 14;11(1):5182
pubmed: 33057025
J Allergy Clin Immunol. 2019 Apr;143(4):1598-1606
pubmed: 30291842
Eur Respir J. 2019 Jul 18;54(1):
pubmed: 31000678
Curr Drug Targets Inflamm Allergy. 2005 Dec;4(6):619-25
pubmed: 17305518
Front Immunol. 2014 Sep 10;5:435
pubmed: 25309536
Eur Respir J Suppl. 2001 Dec;34:50s-59s
pubmed: 12392035
J Epidemiol Community Health. 2009 Oct;63(10):777-83
pubmed: 19468016
Clin Infect Dis. 2001 Jan;32(1):76-102
pubmed: 11118387
Environ Res. 2017 Nov;159:519-530
pubmed: 28888196
Chest. 2022 May;161(5):1155-1166
pubmed: 35104449
Nat Genet. 2019 Mar;51(3):494-505
pubmed: 30804561
N Engl J Med. 2017 Oct 26;377(17):1613-1629
pubmed: 28893134
Cell Host Microbe. 2018 Sep 12;24(3):341-352.e5
pubmed: 30212648

Auteurs

Andi Hudler (A)

Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Anschutz Medical Campus, 12700 East 19th Avenue, 9C03, Aurora, CO 80045, USA.

Fernando Holguin (F)

Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Anschutz Medical Campus, 12700 East 19th Avenue, 9C03, Aurora, CO 80045, USA. Electronic address: Fernando.Holguin@cuanschutz.edu.

Sunita Sharma (S)

Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Anschutz Medical Campus, 12700 East 19th Avenue, 9C03, Aurora, CO 80045, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH